1. Home
  2. SPRB vs ADN Comparison

SPRB vs ADN Comparison

Compare SPRB & ADN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SPRB
  • ADN
  • Stock Information
  • Founded
  • SPRB 2014
  • ADN 2006
  • Country
  • SPRB United States
  • ADN United States
  • Employees
  • SPRB N/A
  • ADN N/A
  • Industry
  • SPRB Medicinal Chemicals and Botanical Products
  • ADN Power Generation
  • Sector
  • SPRB Health Care
  • ADN Utilities
  • Exchange
  • SPRB Nasdaq
  • ADN Nasdaq
  • Market Cap
  • SPRB 15.7M
  • ADN 16.7M
  • IPO Year
  • SPRB 2020
  • ADN N/A
  • Fundamental
  • Price
  • SPRB $0.36
  • ADN $6.96
  • Analyst Decision
  • SPRB Hold
  • ADN
  • Analyst Count
  • SPRB 7
  • ADN 0
  • Target Price
  • SPRB $2.17
  • ADN N/A
  • AVG Volume (30 Days)
  • SPRB 595.7K
  • ADN 38.3K
  • Earning Date
  • SPRB 03-12-2025
  • ADN 12-27-2024
  • Dividend Yield
  • SPRB N/A
  • ADN N/A
  • EPS Growth
  • SPRB N/A
  • ADN N/A
  • EPS
  • SPRB N/A
  • ADN N/A
  • Revenue
  • SPRB $7,101,000.00
  • ADN $8,157,000.00
  • Revenue This Year
  • SPRB N/A
  • ADN $2,232.99
  • Revenue Next Year
  • SPRB N/A
  • ADN $91.56
  • P/E Ratio
  • SPRB N/A
  • ADN N/A
  • Revenue Growth
  • SPRB N/A
  • ADN 274.35
  • 52 Week Low
  • SPRB $0.34
  • ADN $1.71
  • 52 Week High
  • SPRB $5.95
  • ADN $9.54
  • Technical
  • Relative Strength Index (RSI)
  • SPRB 37.97
  • ADN 63.08
  • Support Level
  • SPRB $0.34
  • ADN $5.81
  • Resistance Level
  • SPRB $0.39
  • ADN $7.40
  • Average True Range (ATR)
  • SPRB 0.03
  • ADN 0.74
  • MACD
  • SPRB 0.00
  • ADN 0.15
  • Stochastic Oscillator
  • SPRB 20.73
  • ADN 82.33

About SPRB Spruce Biosciences Inc.

Spruce Biosciences Inc is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with unmet medical needs. The company is initially developing its wholly-owned product candidate, tildacerfont, as the potential first non-steroidal therapy to offer markedly improved disease control and reduce steroid burden for patients suffering from classic congenital adrenal hyperplasia (CAH).

About ADN Advent Technologies Holdings Inc.

Advent Technologies Holdings Inc is an innovation-driven company in the fuel cell and hydrogen technology space. The company develops, manufactures, and assembles complete fuel cell systems and the critical components that determine the performance of hydrogen fuel cells and other energy systems. It serves automotive; aviation and power generation industries. It generates revenue from the sale of fuel cell systems and the sale of MEAs, membranes, and electrodes for specific applications in the fuel cell and energy storage (flow battery) markets.

Share on Social Networks: